James C Momtazee's Net Worth

$1.33 Billion

Estimate Recalculated Jul 1, 2024 08:02PM EST

Who is James C Momtazee?

James C Momtazee has an estimated net worth of $1.33 Billion. This is based on reported shares across multiple companies, which include ACCURIDE CORP, HCA INC/TN, ENTELLUS MEDICAL INC, Roivant Sciences Ltd., BridgeBio Pharma, Inc., Jazz Pharmaceuticals plc, PRA Health Sciences, Inc., ALLIANCE IMAGING INC /DE/, and Montes Archimedes Acquisition Corp.

SEC CIK

James C Momtazee's CIK is 0001209181

Past Insider Trading and Trends

2007 was James C Momtazee's most active year for acquiring shares with 7 total transactions. James C Momtazee's most active month to acquire stocks was the month of July. 2007 was James C Momtazee's most active year for disposing of shares, totalling 6 transactions. James C Momtazee's most active month to dispose stocks was the month of December. 2021 saw James C Momtazee paying a total of $1,160,000.00 for 119,225 shares, this is the most they've acquired in one year. In 2007 James C Momtazee cashed out on 33,403,086 shares for a total of $153,326,699.89, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

HCA INC/TN (HCA) Snapshot price: $307.77

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found

ENTELLUS MEDICAL INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-3.75K
$24.00
-$90,000.00
0
Feb 28
Form 4
∞
3.75K
—
—
3.75K
Jul 14
Form 3
—
0
—
—
0
No matching records found

Roivant Sciences Ltd. (ROIV) Snapshot price: $10.33

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+1.57%
1.2K
$10.90
-$3,193.70
77.54K
Apr 24
Form 4
+2.10%
1.57K
—
—
76.34K
Jan 19
Form 4
+1.23%
907
$10.30
-$7,076.10
74.77K
Oct 16 - Oct 17
Form 4
-8.38%
-6.75K
$11.17
-$75,419.84
73.86K
Sep 18
Form 4
+28.39%
17.82K
—
—
80.61K
Sep 12
Form 4
+2.72%
1.66K
—
—
62.79K
Jul 3
Form 4
+2.26%
1.35K
—
—
61.13K
Apr 3
Form 4
+4.27%
2.45K
—
—
59.77K
Jan 3
Form 4
+6.31%
3.4K
—
—
57.33K
Oct 31
Form 4
+1,274.53%
50K
—
—
53.92K
Sep 15
Form 4
∞
3.92K
—
—
3.92K
Jul 20
Form 3
—
0
—
—
0
No matching records found

BridgeBio Pharma, Inc. (BBIO) Snapshot price: $33.79

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 21
Form 4
—
0
—
—
0
Jun 21
Form 4
—
0
—
—
0
Jun 22
Form 4
+942.17%
80K
$14.50
$1,160,000.00
88.49K
Dec 29
Form 4
—
0
—
—
0
Jun 17
Form 4
—
0
—
—
0
Jun 2
Form 4
∞
8.49K
—
—
8.49K
Feb 12
Form 4
—
0
—
—
0
Dec 12
Form 3
—
0
—
—
0
No matching records found

Jazz Pharmaceuticals plc (JAZZ) Snapshot price: $123.23

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-5.82%
-1.07K
$81.86
-$87,590.20
17.32K
Aug 13
Form 4
+13.94%
2.25K
—
—
18.39K
Aug 8
Form 4
+16.20%
2.25K
—
—
16.14K
Aug 9
Form 3/A
—
0
—
—
0
Form 4/A
-100.00%
-13.88K
—
—
0
Jan 18
Form 3
—
0
—
—
0
Form 4
-100.00%
-13.88K
—
—
0
Jan 18
Form 4
∞
13.88K
$35.11
$61.00
13.88K
Jan 11
Form 4
—
0
—
—
0
Nov 4
Form 4
—
0
—
—
0
Mar 10
Form 4
—
0
—
—
0
Aug 25
Form 4/A
—
0
—
—
0
Aug 17
Form 4
—
0
—
—
0
Aug 17
Form 4/A
—
0
—
—
0
Aug 15
Form 4
—
0
—
—
0
Aug 15
Form 4
—
0
—
—
0
Mar 12
Form 4
—
0
—
—
0
Aug 15
Form 4
∞
8.61M
—
—
8.61M
Jun 6
Form 3
—
0
—
—
0
No matching records found